Results 101 to 110 of about 8,945 (197)

Paranoid psychosis due to flecainide toxicity in malignant neuropathic pain.

open access: yes, 1997
Flecainide was used to treat malignant neuropathic pain but despite using therapeutic doses, toxicity occurred resulting in paranoid psychosis.
Bennett, Michael I.
core  

Axonal Protection Using Flecainide in Experimental Autoimmune Encephalomyelitis

open access: yes, 2004
Axonal degeneration is a major cause of permanent neurological deficit in multiple sclerosis (MS), but no current therapies for the disease are known to be effective at axonal protection.
Kapoor, R   +5 more
core   +1 more source

Paranoid Psychosis and Myoclonus: Flecainide Toxicity in Renal Failure

open access: yes
Flecainide is a sodium channel blocker used mainly in the treatment of supraventricular arrhythmias. Central nervous system side effects such as dizziness, visual disturbances, headache and nausea are commonly associated with flecainide, but severe ...
Maclean D, Sheerin NS, Ting SM, Lee D
core  

Flecainide: long-term treatment using a reduced dosing schedule.

open access: yes, 1985
Flecainide was initially prescribed at a dose of 200 mg twice daily, but after early toxicity in patients with ventricular tachycardia (VT), the dosage was reduced to 100 mg twice daily.
Torres, V   +4 more
core  

Solvates of Flecainide Base

open access: yes, 2008
Flekainīda bāzes solvāti. Ļubova Jansone, darba vadītājs Dr.chem., asoc. prof. Andris Actiņš. Bakalaura darbs 33 lappuses, 19 attēli, 5 tabulas, 15 literatūras avoti. Latviešu valodā.
Jansone, Ļubova
core  

Fulminant flecainide intoxication in an adolescent: cardiogenic shock requiring VA-ECMO support. [PDF]

open access: yesBMJ Case Rep
Kovacevic M   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy